Vol 31, No 3 (2024)
Letter to the Editor
Published online: 2024-06-24

open access

Page views 200
Article views/downloads 97
Get Citation

Connect on Social Media

Connect on Social Media

Optimal antiplatelet therapy in patients with acute coronary syndromes — a still unfulfilled need?

Piotr Adamski1
Pubmed: 38913494
Cardiol J 2024;31(3):504-506.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Kubica J, Adamski P, Niezgoda P, et al. A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study. Cardiol J. 2021; 28(4): 607–614.
  2. Kubica J, Adamski P, Gorog D, et al. Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial. Cardiology Journal. 2022; 29(1): 148–153.
  3. Kim HS, Kang J, Hwang D, et al. Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial. The Lancet. 2020; 396(10257): 1079–1089.
  4. Kim C, Park MW, Kim M, et al. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial. The Lancet. 2021; 398(10308): 1305–1316.
  5. Kwon O, Park DW. Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations. JACC Asia. 2022; 2(1): 1–18.
  6. Kang J, Rizas KD, Park KW, et al. Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis. Eur Heart J. 2023; 44(15): 1360–1370.
  7. Tavenier AH, Mehran R, Chiarito M, et al. Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022; 8(5): 492–502.
  8. Kuno T, Fujisaki T, Shoji S, et al. Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis. Circ Cardiovasc Interv. 2022; 15(8): e011990.
  9. Kuno T, Watanabe A, Shoji S, et al. Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis. Circ Cardiovasc Interv. 2023; 16(9): e013242.